G Venkatraman
Overview
Explore the profile of G Venkatraman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasheed R, Venkatraman G, Vijayalakshmi S, Raja T, Senthil G, Renugadevi P
Indian J Pharmacol
. 2024 Dec;
56(5):317-321.
PMID: 39687954
Background: Long-term metabolic disease type 2 diabetes mellitus (T2DM) is distinguished by elevated blood glucose, insulin resistance, and drought of insulin with dyslipidemia. Oral hypoglycemic agents lower blood glucose levels...
2.
Shewade H, Gupta V, Satyanarayana S, Kharate A, Murali L, Deshpande M, et al.
F1000Res
. 2019 Jul;
8:338.
PMID: 31297190
In 2007, a field observation from India reported 11% misclassification among 'new' patients registered under the revised national tuberculosis (TB) control programme. Ten years down the line, it is important...
3.
Shewade H, Gupta V, Satyanarayana S, Pandey P, Bajpai U, Tripathy J, et al.
PLoS One
. 2019 Mar;
14(3):e0213345.
PMID: 30865730
Background: Axshya SAMVAD is an active tuberculosis (TB) case finding (ACF) strategy under project Axshya (Axshya meaning 'free of TB' and SAMVAD meaning 'conversation') among marginalized and vulnerable populations in...
4.
Shewade H, Gupta V, Satyanarayana S, Kharate A, Sahai K, Murali L, et al.
Glob Health Action
. 2018 Sep;
11(1):1494897.
PMID: 30173603
Background: There is limited evidence on whether active case finding (ACF) among marginalised and vulnerable populations mitigates the financial burden during tuberculosis (TB) diagnosis. Objectives: To determine the effect of...
5.
Beesetti S, Mavuluri J, Surabhi R, Oberyszyn T, Tober K, Pitani R, et al.
Oncogene
. 2017 Jul;
36(44):6154-6163.
PMID: 28692051
Sun-induced skin lesions, in particular actinic keratosis, are generally considered as premalignant skin lesions that can progress into squamous cell carcinoma (SCC) and invasive SCC if left untreated. Therefore, understanding...
6.
Jagadeeshan S, Subramanian A, Tentu S, Beesetti S, Singhal M, Raghavan S, et al.
Ann Oncol
. 2016 Apr;
27(8):1546-56.
PMID: 27117533
Background: Therapeutic resistance to gemcitabine in pancreatic ductal adenocarcinoma (PDAC) is attributed to various cellular mechanisms and signaling molecules that influence as a single factor or in combination. Design: In...
7.
Kumar A, Singhal M, Chopra C, Srinivasan S, Surabhi R, Kanumuri R, et al.
Oncogene
. 2016 Feb;
35(37):4857-65.
PMID: 26898755
P21 Activated Kinase 1 (Pak1), an oncogenic serine/threonine kinase, is known to have a significant role in the regulation of cytoskeleton and cellular morphology. Runx3 was initially known for its...
8.
Jagadeeshan S, Krishnamoorthy Y, Singhal M, Subramanian A, Mavuluri J, Lakshmi A, et al.
Oncogene
. 2014 Feb;
34(4):455-64.
PMID: 24561527
Pancreatic ductal adenocarcinoma (PDAC) is the eighth largest cause of cancer-related mortality across the world, with a median 5-year survival rate of less than 3.5%. This is partly because the...
9.
Sutton D, Davey T, Venkatraman G, Hart K
J Ren Care
. 2009 Feb;
35(1):42-7.
PMID: 19200277
This study examined whether stanols can exert their cholesterol lowering effect in renal transplant recipients who develop hypercholesterolaemia. The rise in cholesterol is related to the use of cyclosporine. The...
10.
Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza J, El-Rifai W, et al.
Br J Cancer
. 2008 Sep;
99(6):949-56.
PMID: 18781152
MUC4 is a large, heavily glycosylated transmembrane mucin, that is implicated in the pathogenesis of various types of cancers. To date, no extensive study has been done to check the...